iMedicalApps
Tuesday, September 15, 2009
Lowering Homocysteine Levels in Kidney Patients Does Not Improve Cognition
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. 09/15/09. Treatment with high daily doses of B vitamins, which decreased total homocysteine levels, did not affect cognitive outcomes in patients with advanced chronic kidney disease and end-stage renal disease. American Journal of Kidney Diseases via PubMed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment